WAC 246-240-075
Training for an authorized nuclear
pharmacist. Except as provided in WAC 246-240-078, the
licensee shall require the authorized nuclear pharmacist to be
a pharmacist who:
(1) Is certified by a specialty board whose certification
process has been recognized by the department, the U.S.
Nuclear Regulatory Commission or an agreement state and who
meets the requirements in subsection (2)(b) of this section.
(Specialty boards whose certification process has been
recognized by the commission or an agreement state will be
posted on the NRC's web page at http://www.nrc.gov.) To be
recognized, a specialty board shall require all candidates for
certification to:
(a) Have graduated from a pharmacy program accredited by
the American Council On Pharmaceutical Education (ACPE) or
have passed the Foreign Pharmacy Graduate Examination
Committee (FPGEC) examination;
(b) Hold a current, active license to practice pharmacy;
(c) Provide evidence of having acquired at least four
thousand hours of training/experience in nuclear pharmacy
practice. Academic training may be substituted for no more
than two thousand hours of the required training and
experience; and
(d) Pass an examination in nuclear pharmacy administered
by diplomates of the specialty board, which assesses knowledge
and competency in procurement, compounding, quality assurance,
dispensing, distribution, health and safety, radiation safety,
provision of information and consultation, monitoring patient
outcomes, research and development; or
(2)(a) Has completed two hundred hours in a structured
educational program consisting of both:
(i) Didactic training in the following areas:
(A) Radiation physics and instrumentation;
(B) Radiation protection;
(C) Mathematics pertaining to the use and measurement of
radioactivity;
(D) Chemistry of radioactive material for medical use;
and
(E) Radiation biology; and
(ii) Supervised practical experience in a nuclear
pharmacy involving:
(A) Shipping, receiving, and performing related radiation
surveys;
(B) Using and performing checks for proper operation of
instruments used to determine the activity of dosages, survey
meters, and, if appropriate, instruments used to measure
alpha-or beta-emitting radionuclides;
(C) Calculating, assaying, and safely preparing dosages
for patients or human research subjects;
(D) Using administrative controls to avoid medical events
in the administration of radioactive material; and
(E) Using procedures to prevent or minimize radioactive
contamination and using proper decontamination procedures; and
(b) Has obtained written certification, signed by a
preceptor authorized nuclear pharmacist, that the individual
has satisfactorily completed the requirements in subsections
(1)(a), (b), and (c) or (2)(a) of this section and has
achieved a level of competency sufficient to function
independently as an authorized nuclear pharmacist.
[Statutory Authority: RCW 70.98.050. 06-05-019, §
246-240-075, filed 2/6/06, effective 3/9/06.]